Cargando…

DPP4/CD26 overexpression in urothelial carcinoma confers an independent prognostic impact and correlates with intrinsic biological aggressiveness

Urothelial carcinoma (UC) is common cancer worldwide. The molecular aberrations regarding tumor progression remain unclear. Pericellular proteolysis is crucial in tumorigenesis, but its significance is unexplored in UC. By data mining the datasets in Gene Expression Omnibus, specifically focus on th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liang, Peir-In, Yeh, Bi-Wen, Li, Wei-Ming, Chan, Ti-Chun, Chang, I-Wei, Huang, Chun-Nung, Li, Ching-Chia, Ke, Hung-Lung, Yeh, Hsin-Chih, Wu, Wen-Jeng, Li, Chien-Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356858/ https://www.ncbi.nlm.nih.gov/pubmed/27936466 http://dx.doi.org/10.18632/oncotarget.13820

Ejemplares similares

MCM10 overexpression implicates adverse prognosis in urothelial carcinoma
por: Li, Wei-Ming, et al.
Publicado: (2016)

DDR2 overexpression in urothelial carcinoma indicates an unfavorable prognosis: a large cohort study
por: Tsai, Meng-Chen, et al.
Publicado: (2016)

Sulfatase-1 overexpression indicates poor prognosis in urothelial carcinoma of the urinary bladder and upper tract
por: Lee, Hsiang-Ying, et al.
Publicado: (2017)

CSF2 Overexpression Is Associated with STAT5 Phosphorylation and Poor Prognosis in Patients with Urothelial Carcinoma
por: Lee, Yi-Ying, et al.
Publicado: (2016)

Role of Microtubule-Associated Protein 1b in Urothelial Carcinoma: Overexpression Predicts Poor Prognosis
por: Chien, Tsu-Ming, et al.
Publicado: (2020)

Complement Component 1, s Subcomponent Overexpression is an Independent Poor Prognostic Indicator in Patients with Urothelial Carcinomas of the Upper Urinary Tract and Urinary Bladder
por: Chang, I-Wei, et al.
Publicado: (2016)

Hypoxia-regulated MicroRNA-210 Overexpression is Associated with Tumor Development and Progression in Upper Tract Urothelial Carcinoma
por: Ke, Hung-Lung, et al.
Publicado: (2017)

Identification of potential genes in upper tract urothelial carcinoma using next-generation sequencing with bioinformatics and in vitro analyses
por: Lee, Hsiang-Ying, et al.
Publicado: (2021)

Necdin Overexpression Predicts Poor Prognosis in Patients with Urothelial Carcinomas of the Upper Urinary Tract and Urinary Bladder
por: Chang, I-Wei, et al.
Publicado: (2016)

Prognostic Utility of FBLN2 Expression in Patients With Urothelial Carcinoma
por: Li, Wei-Ming, et al.
Publicado: (2020)

The diagnostic ureteroscopy before radical nephroureterectomy in upper urinary tract urothelial carcinoma is not associated with higher intravesical recurrence
por: Lee, Hsiang-Ying, et al.
Publicado: (2018)

High Expression of 17β-hydroxysteroid Dehydrogenase Type 2 is Associated with a Better Prognosis in Urothelial Carcinoma of the Urinary Tract
por: Wang, Chieh-Tien, et al.
Publicado: (2016)

Concurrent Preoperative Presence of Hydronephrosis and Flank Pain Independently Predicts Worse Outcome of Upper Tract Urothelial Carcinoma
por: Yeh, Hsin-Chih, et al.
Publicado: (2015)

Downregulation of RNF128 Predicts Progression and Poor Prognosis in Patients with Urothelial Carcinoma of the Upper Tract and Urinary Bladder
por: Lee, Yi-Ying, et al.
Publicado: (2016)

Prognostic Significance of ROR2 Expression in Patients with Urothelial Carcinoma
por: Yeh, Cheng-Fa, et al.
Publicado: (2021)

Prognostic Impact of Thrombospodin-2 (THBS2) Overexpression on Patients with Urothelial Carcinomas of Upper Urinary Tracts and Bladders
por: Chang, I-Wei, et al.
Publicado: (2016)

Deduction of Novel Genes Potentially Involved in Upper Tract Urothelial Carcinoma Using Next-Generation Sequencing and Bioinformatics Approaches
por: Lee, Hsiang-Ying, et al.
Publicado: (2019)

CSF-1 Overexpression Predicts Poor Prognosis in Upper Tract Urothelial Carcinomas
por: Hsu, Wei-Chi, et al.
Publicado: (2019)

Over-expression of Activated Signal Transducer and Activator of Transcription 3 Predicts Poor Prognosis in Upper Tract Urothelial Carcinoma
por: Li, Wei-Ming, et al.
Publicado: (2017)

CEBPD amplification and overexpression in urothelial carcinoma: a driver of tumor metastasis indicating adverse prognosis
por: Wang, Yu-Hui, et al.
Publicado: (2015)

Utility of EFEMP1 in the Prediction of Oncologic Outcomes of Urothelial Carcinoma
por: Chen, Tzu-Ju, et al.
Publicado: (2021)

SPOCK1 Overexpression Confers a Poor Prognosis in Urothelial Carcinoma
por: Ma, Li-Jung, et al.
Publicado: (2016)

Validation of Hyponatremia as a Prognostic Predictor in Multiregional Upper Tract Urothelial Carcinoma
por: Yeh, Hsin-Chih, et al.
Publicado: (2020)

Prognostic Factors for Contralateral Recurrence of Upper Tract Urothelial Carcinoma after Nephroureterectomy: A Large Multiregional Study
por: Chien, Tsu-Ming, et al.
Publicado: (2021)

Prognostic Value of Comorbidity for Patients with Upper Tract Urothelial Carcinoma after Radical Nephroureterectomy
por: Ke, Hung-Lung, et al.
Publicado: (2022)

Low Hemoglobin-to-Red Cell Distribution Width Ratio Is Associated with Disease Progression and Poor Prognosis in Upper Tract Urothelial Carcinoma
por: Su, Yung-Chun, et al.
Publicado: (2021)

SLC14A1 prevents oncometabolite accumulation and recruits HDAC1 to transrepress oncometabolite genes in urothelial carcinoma
por: Chan, Ti-Chun, et al.
Publicado: (2020)

SERPINE2 Overexpression Is Associated with Poor Prognosis of Urothelial Carcinoma
por: Chuang, Hao-Wen, et al.
Publicado: (2021)

Overexpression of Pyruvate Dehydrogenase Kinase-3 Predicts Poor Prognosis in Urothelial Carcinoma
por: Kuo, Yu-Hsuan, et al.
Publicado: (2021)

Predominant global glomerulosclerosis in patients of upper urinary tract urothelial carcinoma with pre-existing renal function impairment is a predictor of poor renal outcomes
por: Niu, Sheng-Wen, et al.
Publicado: (2019)

Upregulation of dihydropyrimidinase-like 3 (DPYSL3) protein predicts poor prognosis in urothelial carcinoma
por: Liang, Peir-In, et al.
Publicado: (2023)

How to manage patients with suspected upper tract urothelial carcinoma in the pandemic of COVID-19?
por: Lee, Hsiang-Ying, et al.
Publicado: (2021)

Amplification-driven BCL6-suppressed cytostasis is mediated by transrepression of FOXO3 and post-translational modifications of FOXO3 in urinary bladder urothelial carcinoma
por: Wu, Wen-Ren, et al.
Publicado: (2020)

DPP‐4 Inhibitor Linagliptin Attenuates Aβ‐induced Cytotoxicity through Activation of AMPK in Neuronal Cells
por: Kornelius, Edy, et al.
Publicado: (2015)

The biological impacts of CEBPD on urothelial carcinoma development and progression
por: Chan, Ti-Chun, et al.
Publicado: (2023)

Biological significance of MYC and CEBPD coamplification in urothelial carcinoma: Multilayered genomic, transcriptional and posttranscriptional positive feedback loops enhance oncogenic glycolysis
por: Chan, Ti‐Chun, et al.
Publicado: (2021)

Overexpression of KLF17 Predicts a Favorable Prognosis in Patients with Oral Squamous Cell Carcinoma: A Retrospective Study
por: Lee, Yi-Ju, et al.
Publicado: (2020)

CTSE Overexpression Is an Adverse Prognostic Factor for Survival among Rectal Cancer Patients Receiving CCRT
por: Chou, Chia-Lin, et al.
Publicado: (2021)

The cAMP responsive element binding protein 1 transactivates epithelial membrane protein 2, a potential tumor suppressor in the urinary bladder urothelial carcinoma
por: Li, Chien-Feng, et al.
Publicado: (2015)

Dipeptidyl peptidase-4 (DPP-4; CD26)
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_5te2lvp1sk6if8o6inkloq3qt7